MIRA Stock Price | MIRA Pharmaceuticals, Inc. Common Stock P/E, Revenue, EPS, & Forecasts

MIRA Pharmaceuticals, Inc. Common Stock • MIRA

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About MIRA Pharmaceuticals, Inc. Common Stock

Ticker

MIRA

Trading on

NASDAQ

ISIN

US60458C1045

Industry

Drug Manufacturers - General

Sector

Healthcare

CEO

Erez Aminov

Headquarters

1200 Brickell Avenue, Miami, FL, United States, 32183

Employees

Website

https://mirapharmaceuticals.com

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.

Metrics

BasicAdvanced

Market cap

$30.4M

P/E ratio

EPS

-$0.47

Dividend Yield

0.00%

Beta

1.75

Forward P/E ratio

EBIDTA

Ex dividend date

Price & volume

Market cap

$30.4M

Average daily volume

8.9M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

Price to book

44.84

Earnings

EPS

-$0.47

EPS estimate (current quarter)

-$0.13

EPS estimate (next quarter)

-$0.09

EBITDA

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

1.75

52-week High

$2.45

52-week Low

$0.73

50-day moving average

$1.43

200-day moving average

$1.28

Short ratio

0.1

Short %

1.96%

Management effectiveness

ROE (TTM)

-556.87%

ROA (TTM)

-253.31%

Profit margin

0.00%

Gross profit margin

$0M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

20.8M

Float

12.7M

Insiders %

36.57%

Institutions %

5.69%

Analyst Insights & forecasts

0% Buy

100% Hold

0% Sell

Based on information from 1 analysts.

Average price target

$10.38

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.14

-$0.11

-27.27%

Q3 • 24Missed

-$0.18

-$0.13

-34.62%

Q4 • 24Missed

-$0.11

-$0.16

31.25%

Q1 • 25Beat

-$0.10

Q2 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$11.2M

$-1.8M

-15.98%

Q1 • 25

$0M

$-1.5M

-∞%

Q2 • 25

-100.00%

-13.79%

∞%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$1.4M

$0.1M

7.58%

Q1 • 25

$0.9M

$0.3M

34.37%

Q2 • 25

-37.99%

181.11%

353.34%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-1.6M

$0M

$-1.6M

Q1 • 25

$-0.8M

$0.3M

$-0.8M

Q2 • 25

-50.94%

9,478.26%

-50.94%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a MIRA Pharmaceuticals, Inc. Common Stock share?

MIRA Pharmaceuticals, Inc. Common Stock shares are currently traded for undefined per share.

How many shares does MIRA Pharmaceuticals, Inc. Common Stock have?

MIRA Pharmaceuticals, Inc. Common Stock currently has 20.8M shares.

Does MIRA Pharmaceuticals, Inc. Common Stock pay dividends?

No, MIRA Pharmaceuticals, Inc. Common Stock doesn't pay dividends.

What is MIRA Pharmaceuticals, Inc. Common Stock 52 week high?

MIRA Pharmaceuticals, Inc. Common Stock 52 week high is $2.45.

What is MIRA Pharmaceuticals, Inc. Common Stock 52 week low?

MIRA Pharmaceuticals, Inc. Common Stock 52 week low is $0.73.

What is the 200-day moving average of MIRA Pharmaceuticals, Inc. Common Stock?

MIRA Pharmaceuticals, Inc. Common Stock 200-day moving average is $1.28.

Who is MIRA Pharmaceuticals, Inc. Common Stock CEO?

The CEO of MIRA Pharmaceuticals, Inc. Common Stock is Erez Aminov.

How many employees MIRA Pharmaceuticals, Inc. Common Stock has?

MIRA Pharmaceuticals, Inc. Common Stock has 0 employees.

What is the market cap of MIRA Pharmaceuticals, Inc. Common Stock?

The market cap of MIRA Pharmaceuticals, Inc. Common Stock is $30.4M.

What is the P/E of MIRA Pharmaceuticals, Inc. Common Stock?

The current P/E of MIRA Pharmaceuticals, Inc. Common Stock is null.

What is the EPS of MIRA Pharmaceuticals, Inc. Common Stock?

The EPS of MIRA Pharmaceuticals, Inc. Common Stock is -$0.47.

What is the PEG Ratio of MIRA Pharmaceuticals, Inc. Common Stock?

The PEG Ratio of MIRA Pharmaceuticals, Inc. Common Stock is null.

What do analysts say about MIRA Pharmaceuticals, Inc. Common Stock?

According to the analysts MIRA Pharmaceuticals, Inc. Common Stock is considered a hold.